nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—Non-Nucleoside Reverse Transcriptase Inhibitors—Delavirdine—acquired immunodeficiency syndrome	0.102	0.157	CiPCiCtD
Efavirenz—Non-Nucleoside Analog—Delavirdine—acquired immunodeficiency syndrome	0.102	0.157	CiPCiCtD
Efavirenz—Cytochrome P450 3A Inducers—Nevirapine—acquired immunodeficiency syndrome	0.0922	0.142	CiPCiCtD
Efavirenz—Non-Nucleoside Reverse Transcriptase Inhibitors—Nevirapine—acquired immunodeficiency syndrome	0.0771	0.119	CiPCiCtD
Efavirenz—Non-Nucleoside Analog—Nevirapine—acquired immunodeficiency syndrome	0.0771	0.119	CiPCiCtD
Efavirenz—Cytochrome P450 2B6 Inducers—Nevirapine—acquired immunodeficiency syndrome	0.0771	0.119	CiPCiCtD
Efavirenz—Cytochrome P450 3A Inducers—Ritonavir—acquired immunodeficiency syndrome	0.0737	0.113	CiPCiCtD
Efavirenz—Cytochrome P450 3A4 Inhibitors—Amprenavir—acquired immunodeficiency syndrome	0.0285	0.0439	CiPCiCtD
Efavirenz—Cytochrome P450 3A4 Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.0203	0.0313	CiPCiCtD
Efavirenz—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0123	0.0491	CbGbCtD
Efavirenz—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0123	0.0491	CbGbCtD
Efavirenz—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0111	0.0444	CbGbCtD
Efavirenz—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.00931	0.0372	CbGbCtD
Efavirenz—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.00842	0.0337	CbGbCtD
Efavirenz—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00781	0.0312	CbGbCtD
Efavirenz—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0072	0.0288	CbGbCtD
Efavirenz—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0072	0.0288	CbGbCtD
Efavirenz—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00706	0.0282	CbGbCtD
Efavirenz—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00706	0.0282	CbGbCtD
Efavirenz—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.00651	0.026	CbGbCtD
Efavirenz—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00649	0.026	CbGbCtD
Efavirenz—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00649	0.026	CbGbCtD
Efavirenz—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00609	0.0244	CbGbCtD
Efavirenz—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00594	0.0237	CbGbCtD
Efavirenz—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00594	0.0237	CbGbCtD
Efavirenz—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00592	0.0237	CbGbCtD
Efavirenz—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00587	0.0235	CbGbCtD
Efavirenz—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00587	0.0235	CbGbCtD
Efavirenz—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00546	0.0218	CbGbCtD
Efavirenz—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00537	0.0215	CbGbCtD
Efavirenz—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00537	0.0215	CbGbCtD
Efavirenz—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00535	0.0214	CbGbCtD
Efavirenz—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00535	0.0214	CbGbCtD
Efavirenz—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00513	0.0205	CbGbCtD
Efavirenz—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00507	0.0203	CbGbCtD
Efavirenz—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00494	0.0197	CbGbCtD
Efavirenz—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00492	0.0197	CbGbCtD
Efavirenz—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00463	0.0185	CbGbCtD
Efavirenz—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0045	0.018	CbGbCtD
Efavirenz—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00445	0.0178	CbGbCtD
Efavirenz—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00445	0.0178	CbGbCtD
Efavirenz—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00426	0.0171	CbGbCtD
Efavirenz—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00407	0.0163	CbGbCtD
Efavirenz—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00407	0.0163	CbGbCtD
Efavirenz—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00377	0.0151	CbGbCtD
Efavirenz—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00377	0.0151	CbGbCtD
Efavirenz—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00341	0.0136	CbGbCtD
Efavirenz—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00341	0.0136	CbGbCtD
Efavirenz—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00295	0.0118	CbGbCtD
Efavirenz—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00286	0.0114	CbGbCtD
Efavirenz—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00259	0.0103	CbGbCtD
Efavirenz—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00259	0.0103	CbGbCtD
Efavirenz—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00248	0.00992	CbGbCtD
Efavirenz—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000259	0.0892	CbGeAlD
Efavirenz—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000212	0.0728	CbGeAlD
Efavirenz—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000203	0.0698	CbGeAlD
Efavirenz—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000201	0.0691	CbGeAlD
Efavirenz—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000153	0.0527	CbGeAlD
Efavirenz—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000151	0.0519	CbGeAlD
Efavirenz—CYP2C19—digestive system—acquired immunodeficiency syndrome	9.97e-05	0.0343	CbGeAlD
Efavirenz—CYP2B6—skin of body—acquired immunodeficiency syndrome	9.76e-05	0.0336	CbGeAlD
Efavirenz—CYP2C19—blood—acquired immunodeficiency syndrome	9.5e-05	0.0327	CbGeAlD
Efavirenz—CYP2C19—vagina—acquired immunodeficiency syndrome	8.81e-05	0.0303	CbGeAlD
Efavirenz—CYP1A2—digestive system—acquired immunodeficiency syndrome	8.15e-05	0.028	CbGeAlD
Efavirenz—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	7.91e-05	0.0272	CbGeAlD
Efavirenz—CYP2B6—digestive system—acquired immunodeficiency syndrome	7.81e-05	0.0268	CbGeAlD
Efavirenz—CYP1A2—blood—acquired immunodeficiency syndrome	7.76e-05	0.0267	CbGeAlD
Efavirenz—CYP2C9—digestive system—acquired immunodeficiency syndrome	7.73e-05	0.0266	CbGeAlD
Efavirenz—CYP2B6—blood—acquired immunodeficiency syndrome	7.44e-05	0.0256	CbGeAlD
Efavirenz—CYP2C9—blood—acquired immunodeficiency syndrome	7.37e-05	0.0253	CbGeAlD
Efavirenz—CYP2B6—vagina—acquired immunodeficiency syndrome	6.9e-05	0.0237	CbGeAlD
Efavirenz—CYP1A2—lung—acquired immunodeficiency syndrome	6.8e-05	0.0234	CbGeAlD
Efavirenz—CYP2B6—lung—acquired immunodeficiency syndrome	6.52e-05	0.0224	CbGeAlD
Efavirenz—CYP2B6—nervous system—acquired immunodeficiency syndrome	6.04e-05	0.0208	CbGeAlD
Efavirenz—CYP3A4—digestive system—acquired immunodeficiency syndrome	5.9e-05	0.0203	CbGeAlD
Efavirenz—CYP2B6—central nervous system—acquired immunodeficiency syndrome	5.81e-05	0.02	CbGeAlD
Efavirenz—CYP2D6—digestive system—acquired immunodeficiency syndrome	5.8e-05	0.02	CbGeAlD
Efavirenz—CYP3A4—blood—acquired immunodeficiency syndrome	5.62e-05	0.0193	CbGeAlD
Efavirenz—CYP2D6—blood—acquired immunodeficiency syndrome	5.53e-05	0.019	CbGeAlD
Efavirenz—CYP2B6—brain—acquired immunodeficiency syndrome	4.62e-05	0.0159	CbGeAlD
Efavirenz—CYP3A4—nervous system—acquired immunodeficiency syndrome	4.56e-05	0.0157	CbGeAlD
Efavirenz—CYP2D6—nervous system—acquired immunodeficiency syndrome	4.49e-05	0.0154	CbGeAlD
Efavirenz—CYP3A4—central nervous system—acquired immunodeficiency syndrome	4.39e-05	0.0151	CbGeAlD
Efavirenz—CYP2D6—central nervous system—acquired immunodeficiency syndrome	4.32e-05	0.0149	CbGeAlD
Efavirenz—CYP2D6—brain—acquired immunodeficiency syndrome	3.43e-05	0.0118	CbGeAlD
Efavirenz—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	2.47e-05	0.000253	CcSEcCtD
Efavirenz—Rash—Didanosine—acquired immunodeficiency syndrome	2.46e-05	0.000253	CcSEcCtD
Efavirenz—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	2.46e-05	0.000253	CcSEcCtD
Efavirenz—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	2.46e-05	0.000253	CcSEcCtD
Efavirenz—Dermatitis—Didanosine—acquired immunodeficiency syndrome	2.46e-05	0.000252	CcSEcCtD
Efavirenz—Cough—Ritonavir—acquired immunodeficiency syndrome	2.45e-05	0.000251	CcSEcCtD
Efavirenz—Headache—Didanosine—acquired immunodeficiency syndrome	2.45e-05	0.000251	CcSEcCtD
Efavirenz—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	2.45e-05	0.000251	CcSEcCtD
Efavirenz—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	2.44e-05	0.00025	CcSEcCtD
Efavirenz—Shock—Delavirdine—acquired immunodeficiency syndrome	2.44e-05	0.00025	CcSEcCtD
Efavirenz—Malaise—Saquinavir—acquired immunodeficiency syndrome	2.44e-05	0.00025	CcSEcCtD
Efavirenz—Somnolence—Indinavir—acquired immunodeficiency syndrome	2.44e-05	0.00025	CcSEcCtD
Efavirenz—Asthenia—Stavudine—acquired immunodeficiency syndrome	2.44e-05	0.00025	CcSEcCtD
Efavirenz—Convulsion—Ritonavir—acquired immunodeficiency syndrome	2.43e-05	0.00025	CcSEcCtD
Efavirenz—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	2.43e-05	0.000249	CcSEcCtD
Efavirenz—Vertigo—Saquinavir—acquired immunodeficiency syndrome	2.43e-05	0.000249	CcSEcCtD
Efavirenz—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	2.43e-05	0.000249	CcSEcCtD
Efavirenz—Hypertension—Ritonavir—acquired immunodeficiency syndrome	2.43e-05	0.000249	CcSEcCtD
Efavirenz—Syncope—Saquinavir—acquired immunodeficiency syndrome	2.43e-05	0.000249	CcSEcCtD
Efavirenz—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	2.42e-05	0.000248	CcSEcCtD
Efavirenz—Tremor—Lamivudine—acquired immunodeficiency syndrome	2.42e-05	0.000248	CcSEcCtD
Efavirenz—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	2.41e-05	0.000248	CcSEcCtD
Efavirenz—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	2.41e-05	0.000247	CcSEcCtD
Efavirenz—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	2.41e-05	0.000247	CcSEcCtD
Efavirenz—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	2.41e-05	0.000247	CcSEcCtD
Efavirenz—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	2.41e-05	0.000247	CcSEcCtD
Efavirenz—Pruritus—Stavudine—acquired immunodeficiency syndrome	2.4e-05	0.000246	CcSEcCtD
Efavirenz—Asthenia—Abacavir—acquired immunodeficiency syndrome	2.4e-05	0.000246	CcSEcCtD
Efavirenz—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	2.4e-05	0.000246	CcSEcCtD
Efavirenz—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	2.39e-05	0.000245	CcSEcCtD
Efavirenz—Chest pain—Ritonavir—acquired immunodeficiency syndrome	2.39e-05	0.000245	CcSEcCtD
Efavirenz—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	2.39e-05	0.000245	CcSEcCtD
Efavirenz—Myalgia—Ritonavir—acquired immunodeficiency syndrome	2.39e-05	0.000245	CcSEcCtD
Efavirenz—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	2.38e-05	0.000245	CcSEcCtD
Efavirenz—Anaemia—Lamivudine—acquired immunodeficiency syndrome	2.38e-05	0.000245	CcSEcCtD
Efavirenz—Anxiety—Ritonavir—acquired immunodeficiency syndrome	2.38e-05	0.000244	CcSEcCtD
Efavirenz—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	2.38e-05	0.000244	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	2.38e-05	0.000244	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	2.37e-05	0.000243	CcSEcCtD
Efavirenz—Pruritus—Abacavir—acquired immunodeficiency syndrome	2.37e-05	0.000243	CcSEcCtD
Efavirenz—Fatigue—Indinavir—acquired immunodeficiency syndrome	2.37e-05	0.000243	CcSEcCtD
Efavirenz—Anorexia—Delavirdine—acquired immunodeficiency syndrome	2.36e-05	0.000242	CcSEcCtD
Efavirenz—Discomfort—Ritonavir—acquired immunodeficiency syndrome	2.36e-05	0.000242	CcSEcCtD
Efavirenz—Cough—Saquinavir—acquired immunodeficiency syndrome	2.36e-05	0.000242	CcSEcCtD
Efavirenz—Angioedema—Lamivudine—acquired immunodeficiency syndrome	2.36e-05	0.000242	CcSEcCtD
Efavirenz—Pain—Indinavir—acquired immunodeficiency syndrome	2.35e-05	0.000241	CcSEcCtD
Efavirenz—Constipation—Indinavir—acquired immunodeficiency syndrome	2.35e-05	0.000241	CcSEcCtD
Efavirenz—Urticaria—Zidovudine—acquired immunodeficiency syndrome	2.34e-05	0.00024	CcSEcCtD
Efavirenz—Convulsion—Saquinavir—acquired immunodeficiency syndrome	2.34e-05	0.00024	CcSEcCtD
Efavirenz—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	2.34e-05	0.00024	CcSEcCtD
Efavirenz—Hypertension—Saquinavir—acquired immunodeficiency syndrome	2.34e-05	0.000239	CcSEcCtD
Efavirenz—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	2.33e-05	0.000239	CcSEcCtD
Efavirenz—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	2.33e-05	0.000239	CcSEcCtD
Efavirenz—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	2.33e-05	0.000239	CcSEcCtD
Efavirenz—Malaise—Lamivudine—acquired immunodeficiency syndrome	2.33e-05	0.000239	CcSEcCtD
Efavirenz—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	2.32e-05	0.000238	CcSEcCtD
Efavirenz—Nausea—Didanosine—acquired immunodeficiency syndrome	2.32e-05	0.000238	CcSEcCtD
Efavirenz—Vertigo—Lamivudine—acquired immunodeficiency syndrome	2.32e-05	0.000238	CcSEcCtD
Efavirenz—Syncope—Lamivudine—acquired immunodeficiency syndrome	2.31e-05	0.000237	CcSEcCtD
Efavirenz—Confusional state—Ritonavir—acquired immunodeficiency syndrome	2.31e-05	0.000237	CcSEcCtD
Efavirenz—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	2.3e-05	0.000236	CcSEcCtD
Efavirenz—Myalgia—Saquinavir—acquired immunodeficiency syndrome	2.3e-05	0.000236	CcSEcCtD
Efavirenz—Chest pain—Saquinavir—acquired immunodeficiency syndrome	2.3e-05	0.000236	CcSEcCtD
Efavirenz—Anxiety—Saquinavir—acquired immunodeficiency syndrome	2.29e-05	0.000235	CcSEcCtD
Efavirenz—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	2.29e-05	0.000235	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	2.29e-05	0.000234	CcSEcCtD
Efavirenz—Discomfort—Saquinavir—acquired immunodeficiency syndrome	2.28e-05	0.000233	CcSEcCtD
Efavirenz—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	2.27e-05	0.000233	CcSEcCtD
Efavirenz—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	2.26e-05	0.000232	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	2.26e-05	0.000232	CcSEcCtD
Efavirenz—Shock—Ritonavir—acquired immunodeficiency syndrome	2.26e-05	0.000231	CcSEcCtD
Efavirenz—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	2.25e-05	0.000231	CcSEcCtD
Efavirenz—Cough—Lamivudine—acquired immunodeficiency syndrome	2.25e-05	0.000231	CcSEcCtD
Efavirenz—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	2.25e-05	0.000231	CcSEcCtD
Efavirenz—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	2.25e-05	0.000231	CcSEcCtD
Efavirenz—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	2.25e-05	0.00023	CcSEcCtD
Efavirenz—Dizziness—Stavudine—acquired immunodeficiency syndrome	2.24e-05	0.00023	CcSEcCtD
Efavirenz—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	2.24e-05	0.00023	CcSEcCtD
Efavirenz—Insomnia—Delavirdine—acquired immunodeficiency syndrome	2.24e-05	0.00023	CcSEcCtD
Efavirenz—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	2.24e-05	0.000229	CcSEcCtD
Efavirenz—Convulsion—Lamivudine—acquired immunodeficiency syndrome	2.24e-05	0.000229	CcSEcCtD
Efavirenz—Vomiting—Nevirapine—acquired immunodeficiency syndrome	2.24e-05	0.000229	CcSEcCtD
Efavirenz—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	2.23e-05	0.000228	CcSEcCtD
Efavirenz—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	2.23e-05	0.000228	CcSEcCtD
Efavirenz—Confusional state—Saquinavir—acquired immunodeficiency syndrome	2.23e-05	0.000228	CcSEcCtD
Efavirenz—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	2.22e-05	0.000227	CcSEcCtD
Efavirenz—Rash—Nevirapine—acquired immunodeficiency syndrome	2.22e-05	0.000227	CcSEcCtD
Efavirenz—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	2.21e-05	0.000227	CcSEcCtD
Efavirenz—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	2.21e-05	0.000227	CcSEcCtD
Efavirenz—Dizziness—Abacavir—acquired immunodeficiency syndrome	2.21e-05	0.000227	CcSEcCtD
Efavirenz—Somnolence—Delavirdine—acquired immunodeficiency syndrome	2.2e-05	0.000226	CcSEcCtD
Efavirenz—Headache—Nevirapine—acquired immunodeficiency syndrome	2.2e-05	0.000226	CcSEcCtD
Efavirenz—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	2.2e-05	0.000225	CcSEcCtD
Efavirenz—Myalgia—Lamivudine—acquired immunodeficiency syndrome	2.2e-05	0.000225	CcSEcCtD
Efavirenz—Chest pain—Lamivudine—acquired immunodeficiency syndrome	2.2e-05	0.000225	CcSEcCtD
Efavirenz—Anxiety—Lamivudine—acquired immunodeficiency syndrome	2.19e-05	0.000224	CcSEcCtD
Efavirenz—Anorexia—Ritonavir—acquired immunodeficiency syndrome	2.19e-05	0.000224	CcSEcCtD
Efavirenz—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	2.18e-05	0.000224	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	2.18e-05	0.000224	CcSEcCtD
Efavirenz—Urticaria—Indinavir—acquired immunodeficiency syndrome	2.18e-05	0.000223	CcSEcCtD
Efavirenz—Shock—Saquinavir—acquired immunodeficiency syndrome	2.17e-05	0.000223	CcSEcCtD
Efavirenz—Discomfort—Lamivudine—acquired immunodeficiency syndrome	2.17e-05	0.000223	CcSEcCtD
Efavirenz—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	2.17e-05	0.000222	CcSEcCtD
Efavirenz—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	2.17e-05	0.000222	CcSEcCtD
Efavirenz—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	2.16e-05	0.000222	CcSEcCtD
Efavirenz—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	2.16e-05	0.000222	CcSEcCtD
Efavirenz—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	2.16e-05	0.000222	CcSEcCtD
Efavirenz—Vomiting—Stavudine—acquired immunodeficiency syndrome	2.16e-05	0.000221	CcSEcCtD
Efavirenz—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	2.16e-05	0.000221	CcSEcCtD
Efavirenz—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	2.15e-05	0.00022	CcSEcCtD
Efavirenz—Rash—Nelfinavir—acquired immunodeficiency syndrome	2.15e-05	0.00022	CcSEcCtD
Efavirenz—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	2.14e-05	0.00022	CcSEcCtD
Efavirenz—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	2.14e-05	0.00022	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	2.14e-05	0.00022	CcSEcCtD
Efavirenz—Rash—Stavudine—acquired immunodeficiency syndrome	2.14e-05	0.000219	CcSEcCtD
Efavirenz—Fatigue—Delavirdine—acquired immunodeficiency syndrome	2.14e-05	0.000219	CcSEcCtD
Efavirenz—Dermatitis—Stavudine—acquired immunodeficiency syndrome	2.14e-05	0.000219	CcSEcCtD
Efavirenz—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	2.13e-05	0.000219	CcSEcCtD
Efavirenz—Headache—Nelfinavir—acquired immunodeficiency syndrome	2.13e-05	0.000219	CcSEcCtD
Efavirenz—Headache—Stavudine—acquired immunodeficiency syndrome	2.13e-05	0.000218	CcSEcCtD
Efavirenz—Vomiting—Abacavir—acquired immunodeficiency syndrome	2.13e-05	0.000218	CcSEcCtD
Efavirenz—Confusional state—Lamivudine—acquired immunodeficiency syndrome	2.12e-05	0.000218	CcSEcCtD
Efavirenz—Pain—Delavirdine—acquired immunodeficiency syndrome	2.12e-05	0.000217	CcSEcCtD
Efavirenz—Constipation—Delavirdine—acquired immunodeficiency syndrome	2.12e-05	0.000217	CcSEcCtD
Efavirenz—Asthenia—Zidovudine—acquired immunodeficiency syndrome	2.12e-05	0.000217	CcSEcCtD
Efavirenz—Rash—Abacavir—acquired immunodeficiency syndrome	2.11e-05	0.000216	CcSEcCtD
Efavirenz—Dermatitis—Abacavir—acquired immunodeficiency syndrome	2.11e-05	0.000216	CcSEcCtD
Efavirenz—Anorexia—Saquinavir—acquired immunodeficiency syndrome	2.1e-05	0.000216	CcSEcCtD
Efavirenz—Headache—Abacavir—acquired immunodeficiency syndrome	2.09e-05	0.000215	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	2.09e-05	0.000214	CcSEcCtD
Efavirenz—Nausea—Nevirapine—acquired immunodeficiency syndrome	2.09e-05	0.000214	CcSEcCtD
Efavirenz—Pruritus—Zidovudine—acquired immunodeficiency syndrome	2.09e-05	0.000214	CcSEcCtD
Efavirenz—Insomnia—Ritonavir—acquired immunodeficiency syndrome	2.07e-05	0.000213	CcSEcCtD
Efavirenz—Shock—Lamivudine—acquired immunodeficiency syndrome	2.07e-05	0.000212	CcSEcCtD
Efavirenz—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	2.07e-05	0.000212	CcSEcCtD
Efavirenz—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	2.06e-05	0.000211	CcSEcCtD
Efavirenz—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	2.06e-05	0.000211	CcSEcCtD
Efavirenz—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	2.05e-05	0.00021	CcSEcCtD
Efavirenz—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	2.04e-05	0.00021	CcSEcCtD
Efavirenz—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	2.04e-05	0.00021	CcSEcCtD
Efavirenz—Somnolence—Ritonavir—acquired immunodeficiency syndrome	2.04e-05	0.000209	CcSEcCtD
Efavirenz—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	2.04e-05	0.000209	CcSEcCtD
Efavirenz—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	2.03e-05	0.000208	CcSEcCtD
Efavirenz—Nausea—Nelfinavir—acquired immunodeficiency syndrome	2.02e-05	0.000207	CcSEcCtD
Efavirenz—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	2.02e-05	0.000207	CcSEcCtD
Efavirenz—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	2.02e-05	0.000207	CcSEcCtD
Efavirenz—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	2.02e-05	0.000207	CcSEcCtD
Efavirenz—Nausea—Stavudine—acquired immunodeficiency syndrome	2.02e-05	0.000207	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	2.01e-05	0.000206	CcSEcCtD
Efavirenz—Anorexia—Lamivudine—acquired immunodeficiency syndrome	2.01e-05	0.000206	CcSEcCtD
Efavirenz—Insomnia—Saquinavir—acquired immunodeficiency syndrome	2e-05	0.000205	CcSEcCtD
Efavirenz—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	1.99e-05	0.000204	CcSEcCtD
Efavirenz—Nausea—Abacavir—acquired immunodeficiency syndrome	1.99e-05	0.000204	CcSEcCtD
Efavirenz—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	1.98e-05	0.000203	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	1.98e-05	0.000203	CcSEcCtD
Efavirenz—Fatigue—Ritonavir—acquired immunodeficiency syndrome	1.98e-05	0.000203	CcSEcCtD
Efavirenz—Urticaria—Delavirdine—acquired immunodeficiency syndrome	1.97e-05	0.000202	CcSEcCtD
Efavirenz—Asthenia—Indinavir—acquired immunodeficiency syndrome	1.97e-05	0.000202	CcSEcCtD
Efavirenz—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	1.97e-05	0.000202	CcSEcCtD
Efavirenz—Somnolence—Saquinavir—acquired immunodeficiency syndrome	1.96e-05	0.000201	CcSEcCtD
Efavirenz—Pain—Ritonavir—acquired immunodeficiency syndrome	1.96e-05	0.000201	CcSEcCtD
Efavirenz—Constipation—Ritonavir—acquired immunodeficiency syndrome	1.96e-05	0.000201	CcSEcCtD
Efavirenz—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	1.96e-05	0.000201	CcSEcCtD
Efavirenz—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	1.96e-05	0.000201	CcSEcCtD
Efavirenz—Dizziness—Zidovudine—acquired immunodeficiency syndrome	1.95e-05	0.0002	CcSEcCtD
Efavirenz—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	1.94e-05	0.000199	CcSEcCtD
Efavirenz—Pruritus—Indinavir—acquired immunodeficiency syndrome	1.94e-05	0.000199	CcSEcCtD
Efavirenz—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	1.92e-05	0.000197	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	1.92e-05	0.000197	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	1.91e-05	0.000195	CcSEcCtD
Efavirenz—Insomnia—Lamivudine—acquired immunodeficiency syndrome	1.9e-05	0.000195	CcSEcCtD
Efavirenz—Fatigue—Saquinavir—acquired immunodeficiency syndrome	1.9e-05	0.000195	CcSEcCtD
Efavirenz—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	1.89e-05	0.000194	CcSEcCtD
Efavirenz—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	1.89e-05	0.000194	CcSEcCtD
Efavirenz—Constipation—Saquinavir—acquired immunodeficiency syndrome	1.89e-05	0.000194	CcSEcCtD
Efavirenz—Pain—Saquinavir—acquired immunodeficiency syndrome	1.89e-05	0.000194	CcSEcCtD
Efavirenz—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	1.88e-05	0.000192	CcSEcCtD
Efavirenz—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	1.88e-05	0.000192	CcSEcCtD
Efavirenz—Vomiting—Zidovudine—acquired immunodeficiency syndrome	1.88e-05	0.000192	CcSEcCtD
Efavirenz—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	1.88e-05	0.000192	CcSEcCtD
Efavirenz—Somnolence—Lamivudine—acquired immunodeficiency syndrome	1.87e-05	0.000192	CcSEcCtD
Efavirenz—Rash—Zidovudine—acquired immunodeficiency syndrome	1.86e-05	0.000191	CcSEcCtD
Efavirenz—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	1.86e-05	0.000191	CcSEcCtD
Efavirenz—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	1.85e-05	0.00019	CcSEcCtD
Efavirenz—Headache—Zidovudine—acquired immunodeficiency syndrome	1.85e-05	0.000189	CcSEcCtD
Efavirenz—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	1.83e-05	0.000188	CcSEcCtD
Efavirenz—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	1.83e-05	0.000187	CcSEcCtD
Efavirenz—Urticaria—Ritonavir—acquired immunodeficiency syndrome	1.82e-05	0.000187	CcSEcCtD
Efavirenz—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	1.82e-05	0.000187	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	1.82e-05	0.000186	CcSEcCtD
Efavirenz—Fatigue—Lamivudine—acquired immunodeficiency syndrome	1.82e-05	0.000186	CcSEcCtD
Efavirenz—Dizziness—Indinavir—acquired immunodeficiency syndrome	1.81e-05	0.000186	CcSEcCtD
Efavirenz—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	1.81e-05	0.000186	CcSEcCtD
Efavirenz—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	1.81e-05	0.000186	CcSEcCtD
Efavirenz—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	1.81e-05	0.000185	CcSEcCtD
Efavirenz—Constipation—Lamivudine—acquired immunodeficiency syndrome	1.8e-05	0.000185	CcSEcCtD
Efavirenz—Pain—Lamivudine—acquired immunodeficiency syndrome	1.8e-05	0.000185	CcSEcCtD
Efavirenz—Asthenia—Delavirdine—acquired immunodeficiency syndrome	1.78e-05	0.000182	CcSEcCtD
Efavirenz—Pruritus—Delavirdine—acquired immunodeficiency syndrome	1.75e-05	0.00018	CcSEcCtD
Efavirenz—Urticaria—Saquinavir—acquired immunodeficiency syndrome	1.75e-05	0.00018	CcSEcCtD
Efavirenz—Nausea—Zidovudine—acquired immunodeficiency syndrome	1.75e-05	0.00018	CcSEcCtD
Efavirenz—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	1.75e-05	0.000179	CcSEcCtD
Efavirenz—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	1.75e-05	0.000179	CcSEcCtD
Efavirenz—Vomiting—Indinavir—acquired immunodeficiency syndrome	1.74e-05	0.000179	CcSEcCtD
Efavirenz—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	1.74e-05	0.000178	CcSEcCtD
Efavirenz—Rash—Indinavir—acquired immunodeficiency syndrome	1.73e-05	0.000177	CcSEcCtD
Efavirenz—Dermatitis—Indinavir—acquired immunodeficiency syndrome	1.73e-05	0.000177	CcSEcCtD
Efavirenz—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	1.72e-05	0.000177	CcSEcCtD
Efavirenz—Headache—Indinavir—acquired immunodeficiency syndrome	1.72e-05	0.000176	CcSEcCtD
Efavirenz—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	1.7e-05	0.000174	CcSEcCtD
Efavirenz—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	1.69e-05	0.000173	CcSEcCtD
Efavirenz—Urticaria—Lamivudine—acquired immunodeficiency syndrome	1.67e-05	0.000172	CcSEcCtD
Efavirenz—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	1.66e-05	0.000171	CcSEcCtD
Efavirenz—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	1.66e-05	0.000171	CcSEcCtD
Efavirenz—Asthenia—Ritonavir—acquired immunodeficiency syndrome	1.65e-05	0.000169	CcSEcCtD
Efavirenz—Dizziness—Delavirdine—acquired immunodeficiency syndrome	1.64e-05	0.000168	CcSEcCtD
Efavirenz—Nausea—Indinavir—acquired immunodeficiency syndrome	1.63e-05	0.000167	CcSEcCtD
Efavirenz—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	1.63e-05	0.000167	CcSEcCtD
Efavirenz—Pruritus—Ritonavir—acquired immunodeficiency syndrome	1.62e-05	0.000166	CcSEcCtD
Efavirenz—Asthenia—Saquinavir—acquired immunodeficiency syndrome	1.58e-05	0.000162	CcSEcCtD
Efavirenz—Vomiting—Delavirdine—acquired immunodeficiency syndrome	1.58e-05	0.000162	CcSEcCtD
Efavirenz—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	1.57e-05	0.000161	CcSEcCtD
Efavirenz—Rash—Delavirdine—acquired immunodeficiency syndrome	1.56e-05	0.00016	CcSEcCtD
Efavirenz—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	1.56e-05	0.00016	CcSEcCtD
Efavirenz—Pruritus—Saquinavir—acquired immunodeficiency syndrome	1.56e-05	0.00016	CcSEcCtD
Efavirenz—Headache—Delavirdine—acquired immunodeficiency syndrome	1.55e-05	0.000159	CcSEcCtD
Efavirenz—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	1.55e-05	0.000159	CcSEcCtD
Efavirenz—Dizziness—Ritonavir—acquired immunodeficiency syndrome	1.52e-05	0.000155	CcSEcCtD
Efavirenz—Asthenia—Lamivudine—acquired immunodeficiency syndrome	1.51e-05	0.000155	CcSEcCtD
Efavirenz—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	1.51e-05	0.000155	CcSEcCtD
Efavirenz—Pruritus—Lamivudine—acquired immunodeficiency syndrome	1.49e-05	0.000153	CcSEcCtD
Efavirenz—Nausea—Delavirdine—acquired immunodeficiency syndrome	1.47e-05	0.000151	CcSEcCtD
Efavirenz—Dizziness—Saquinavir—acquired immunodeficiency syndrome	1.46e-05	0.00015	CcSEcCtD
Efavirenz—Vomiting—Ritonavir—acquired immunodeficiency syndrome	1.46e-05	0.00015	CcSEcCtD
Efavirenz—Rash—Ritonavir—acquired immunodeficiency syndrome	1.45e-05	0.000148	CcSEcCtD
Efavirenz—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	1.44e-05	0.000148	CcSEcCtD
Efavirenz—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	1.44e-05	0.000148	CcSEcCtD
Efavirenz—Headache—Ritonavir—acquired immunodeficiency syndrome	1.44e-05	0.000147	CcSEcCtD
Efavirenz—Vomiting—Saquinavir—acquired immunodeficiency syndrome	1.4e-05	0.000144	CcSEcCtD
Efavirenz—Dizziness—Lamivudine—acquired immunodeficiency syndrome	1.39e-05	0.000143	CcSEcCtD
Efavirenz—Rash—Saquinavir—acquired immunodeficiency syndrome	1.39e-05	0.000143	CcSEcCtD
Efavirenz—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	1.39e-05	0.000143	CcSEcCtD
Efavirenz—Headache—Saquinavir—acquired immunodeficiency syndrome	1.38e-05	0.000142	CcSEcCtD
Efavirenz—Nausea—Ritonavir—acquired immunodeficiency syndrome	1.36e-05	0.00014	CcSEcCtD
Efavirenz—Vomiting—Lamivudine—acquired immunodeficiency syndrome	1.34e-05	0.000137	CcSEcCtD
Efavirenz—Rash—Lamivudine—acquired immunodeficiency syndrome	1.33e-05	0.000136	CcSEcCtD
Efavirenz—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	1.33e-05	0.000136	CcSEcCtD
Efavirenz—Headache—Lamivudine—acquired immunodeficiency syndrome	1.32e-05	0.000135	CcSEcCtD
Efavirenz—Nausea—Saquinavir—acquired immunodeficiency syndrome	1.31e-05	0.000134	CcSEcCtD
Efavirenz—Nausea—Lamivudine—acquired immunodeficiency syndrome	1.25e-05	0.000128	CcSEcCtD
